摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-溴-3-(甲基磺酰基)-5-(三氟甲基)苯 | 1215205-96-1

中文名称
1-溴-3-(甲基磺酰基)-5-(三氟甲基)苯
中文别名
——
英文名称
1-bromo-3-(methylsulfonyl)-5-(trifluoromethyl)benzene
英文别名
1-bromo-3-methylsulfonyl-5-(trifluoromethyl)benzene
1-溴-3-(甲基磺酰基)-5-(三氟甲基)苯化学式
CAS
1215205-96-1
化学式
C8H6BrF3O2S
mdl
——
分子量
303.1
InChiKey
XYPYTUQQTPNHKI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    344.5±42.0 °C(Predicted)
  • 密度:
    1.675±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2904909090

SDS

SDS:584ccb5d85b8313deee974f698d132ed
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Bromo-3-(methylsulfonyl)-5-(trifluoromethyl)benzene
Synonyms: 3-Bromo-5-(methylsulfonyl)benzotrifluoride

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-Bromo-3-(methylsulfonyl)-5-(trifluoromethyl)benzene
CAS number: 1215205-96-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6BrF3O2S
Molecular weight: 303.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 3-AMINO-PYRIDINES AS GPBAR1 AGONISTS
    申请人:Bissantz Caterina
    公开号:US20120232051A1
    公开(公告)日:2012-09-13
    This invention relates to novel 3-aminopyridines of the formula wherein B 1 , B 2 and R 1 to R 6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
    这项发明涉及以下结构的新型3-氨基吡啶: 其中B1、B2和R1至R6如描述和索赔中所定义,并且其药学上可接受的盐。这些化合物是GPBAR1激动剂,可用作治疗诸如2型糖尿病等疾病的药物。
  • [EN] COMPOSITIONS AND METHODS FOR INHIBITING BMP<br/>[FR] COMPOSITIONS ET PROCÉDÉS D'INHIBITION DE LA BMP
    申请人:BRIGHAM & WOMENS HOSPITAL
    公开号:WO2016011019A1
    公开(公告)日:2016-01-21
    The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
    本发明提供了BMP信号通路的小分子抑制剂,以及用于抑制BMP信号通路的组合物和方法。这些化合物和组合物可用于调节细胞生长、分化、增殖和凋亡,因此可用于治疗与BMP信号通路相关的疾病或症状,包括炎症、心血管疾病、血液疾病、癌症和骨骼疾病,以及用于调节细胞分化和/或增殖。这些化合物和组合物还可用于降低ApoB-100或LDL的循环水平,并治疗或预防获得性或先天性高胆固醇血症或高脂蛋白血症;与脂质吸收或代谢缺陷相关的疾病、紊乱或综合征;或由高脂血症引起的疾病、紊乱或综合征。
  • [EN] TYK-2 INHIBITOR<br/>[FR] INHIBITEUR DE TYK -2
    申请人:BEIGENE LTD
    公开号:WO2021259208A1
    公开(公告)日:2021-12-30
    Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating a disease associated with the undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.
    本发明公开了一种式I化合物,用于抑制TYK2并治疗与不良tyk-2活性相关的疾病(tyk-2相关疾病),使用本发明所述化合物治疗炎症或自身免疫疾病的方法,以及包含所述化合物的药物组合物。
  • Trifluoromethylation of Arylsilanes with [(phen)CuCF<sub>3</sub> ]
    作者:Johannes Morstein、Haiyun Hou、Chen Cheng、John F. Hartwig
    DOI:10.1002/anie.201601163
    日期:2016.7.4
    A method for the trifluoromethylation of arylsilanes is reported. The reaction proceeds with [(phen)CuCF3] as the CF3 source under mild, oxidative conditions with high functional‐group compatibility. This transformation complements prior trifluoromethylation of arenes in several ways. Most important, this method converts arylsilanes formed by the silylation of aryl C−H bonds to trifluoromethylarenes
    报道了芳基硅烷的三氟甲基化方法。该反应以[(phen)CuCF 3 ]作为CF 3 源,在温和的氧化条件下进行,具有高官能团相容性。这种转化以多种方式补充了先前的芳烃三氟甲基化。最重要的是,该方法将芳基CH键甲硅烷基化形成的芳基硅烷转化为三氟甲基芳烃,从而允许芳烃转化为三氟甲基芳烃。所报道方法的独特能力通过将活性药物成分中的CH键转化为C-CF 3键来证明,这些成分不会通过替代功能化过程(包括硼酸化和三氟甲基化的组合)进行这种整体转变。
  • Decarbonylative Fluoroalkylation at Palladium(II): From Fundamental Organometallic Studies to Catalysis
    作者:Naish Lalloo、Christian A. Malapit、S. Maryamdokht Taimoory、Conor E. Brigham、Melanie S. Sanford
    DOI:10.1021/jacs.1c08551
    日期:2021.11.10
    acid-derived electrophiles [RFC(O)X] with aryl organometallics (Ar–M′). This reaction was optimized by interrogating the individual steps of the catalytic cycle (oxidative addition, carbonyl de-insertion, transmetalation, and reductive elimination) to identify a compatible pair of coupling partners and an appropriate Pd catalyst. These stoichiometric organometallic studies revealed several critical elements
    本文介绍了脱羰基 Pd 催化的芳基-氟烷基成键反应的发展,该反应将氟烷基羧酸衍生的亲电子试剂 [ RF C (O)X] 与芳基有机金属化合物 (Ar-M') 偶联。通过询问催化循环的各个步骤(氧化加成、羰基脱插入、金属转移和还原消除)来优化该反应,以确定一对相容的偶联伙伴和合适的 Pd 催化剂。这些化学计量有机金属研究揭示了反应设计的几个关键要素。首先,使用 M' = 硼酸酯可以避免R F C(O)X 和 Ar–M'之间未催化的背景反应。二、羰基脱嵌和Ar-R F当 R F = CF 3时,还原消除是催化循环中最慢的两个步骤。更改为 R F = CHF 2后,这两个步骤都会显着加快。计算研究表明,有利的 F 2 C–H---X 相互作用有助于加速该系统中的羰基脱嵌。最后,X = 二氟乙酸盐的金属转移速度较慢,但​​ X = F 的金属转移速度较快。最终,这些研究促成了 (SPhos)Pd
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐